These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 33234101)

  • 1. Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak.
    Tandon N; Luxami V; Tandon R; Paul K
    Mini Rev Med Chem; 2021; 21(8):952-968. PubMed ID: 33234101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.
    Al-Bari AA
    Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing anticancer drugs for the management of COVID-19.
    El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
    Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials.
    Paul SS; Biswas G
    Mini Rev Med Chem; 2021; 21(9):1123-1143. PubMed ID: 33355053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
    Goel B; Bhardwaj N; Tripathi N; Jain SK
    Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.
    Jan JT; Cheng TR; Juang YP; Ma HH; Wu YT; Yang WB; Cheng CW; Chen X; Chou TH; Shie JJ; Cheng WC; Chein RJ; Mao SS; Liang PH; Ma C; Hung SC; Wong CH
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33452205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.
    Batalha PN; Forezi LSM; Lima CGS; Pauli FP; Boechat FCS; de Souza MCBV; Cunha AC; Ferreira VF; da Silva FC
    Bioorg Chem; 2021 Jan; 106():104488. PubMed ID: 33261844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.
    Won JH; Lee H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of COVID 19-Repurposing drugs commonly used in dermatology.
    Stojkovic-Filipovic J; Bosic M
    Dermatol Ther; 2020 Sep; 33(5):e13829. PubMed ID: 32542964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19.
    Apaydın ÇB; Çınar G; Cihan-Üstündağ G
    Curr Drug Targets; 2021; 22(17):1986-2005. PubMed ID: 33588727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on emerging therapeutics to combat COVID-19.
    Shah NN; Nabi SU; Rather MA; Kalwar Q; Ali SI; Sheikh WM; Ganai A; Bashir SM
    Basic Clin Pharmacol Toxicol; 2021 Aug; 129(2):104-129. PubMed ID: 33977663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2.
    Xiao X; Wang C; Chang D; Wang Y; Dong X; Jiao T; Zhao Z; Ren L; Dela Cruz CS; Sharma L; Lei X; Wang J
    Front Immunol; 2020; 11():586572. PubMed ID: 33324406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs against SARS-CoV-2: What do we know about their mode of action?
    Valle C; Martin B; Touret F; Shannon A; Canard B; Guillemot JC; Coutard B; Decroly E
    Rev Med Virol; 2020 Nov; 30(6):1-10. PubMed ID: 32779326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
    Lentini G; Cavalluzzi MM; Habtemariam S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
    Altulea D; Maassen S; Baranov MV; van den Bogaart G
    J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.